Legend Biotech Corp Key Management Personnel Compensation Share-based Payment
Legend Biotech Corp (LEGN) reported Key Management Personnel Compensation Share-based Payment of $15.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2026-03-10
- Legend Biotech Corp key management personnel compensation share-based payment for the quarter ending 2023-12-31 was $3.17M, a 249.50% increase year-over-year.
- Legend Biotech Corp key management personnel compensation share-based payment for the quarter ending 2023-09-30 was $1.82M, a 25.27% increase year-over-year.
- Legend Biotech Corp key management personnel compensation share-based payment for the quarter ending 2022-12-31 was $907.00K.
- Legend Biotech Corp key management personnel compensation share-based payment for the quarter ending 2022-09-30 was $1.46M.
| Period end | Key Management Personnel Compensation Share-based Payment 3 month | Key Management Personnel Compensation Share-based Payment 6 month | Key Management Personnel Compensation Share-based Payment 9 month | Key Management Personnel Compensation Share-based Payment 12 month | Key Management Personnel Compensation Share-based Payment 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $15.50M 20-F · filed 2026-03-10 | ||||
| 2024-12-31 | $23.40M 20-F · filed 2026-03-10 | $23.38M 20-F · filed 2025-03-11 | |||
| 2023-12-31 | $3.17M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $4.99M derived: sum of 2 quarters · filed 2026-03-10 | $8.00M 20-F · filed 2026-03-10 | $8.04M 20-F · filed 2024-03-19 | |
| 2023-09-30 | $1.82M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $4.83M 6-K · filed 2023-11-20 | |||
| 2023-06-30 | $3.01M 6-K · filed 2023-08-15 | ||||
| 2022-12-31 | $907.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $2.36M derived: sum of 2 quarters · filed 2025-03-11 | $3.58M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | $1.46M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $2.67M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $1.22M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $2.91M 20-F · filed 2024-03-19 | ||||
| 2021-06-30 | $1.13M 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | $529.00K 20-F · filed 2023-03-30 | ||||
| 2020-06-30 | $306.00K 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | $590.00K 20-F/A · filed 2023-02-17 | ||||
| 2018-12-31 | $210.00K 20-F · filed 2021-04-02 |